AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Non-contact Proactive Remote Monitoring of COPD Exacerbations

Recruitingn/aAges 18 Years - anyAllLife Detection Technologies
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are: * Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT? Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Confirmed diagnosis of COPD 2. 1 or more exacerbation in the last year 3. Aged over 18 years 4. Willing to use monitoring devices and complete study questionnaires 5. Adequate English 6. Signed consent form Exclusion Criteria: 1. Pregnancy 2. BMI greater than 45 kg/m2 3. Nil other, provided inclusion criteria are met.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Royal Free Hospital
London, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy